Coastal Investment Advisors Inc. lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 1.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,372 shares of the healthcare conglomerate’s stock after selling 105 shares during the quarter. Coastal Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $1,169,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Neville Rodie & Shaw Inc. lifted its holdings in UnitedHealth Group by 10.5% during the second quarter. Neville Rodie & Shaw Inc. now owns 37,933 shares of the healthcare conglomerate’s stock worth $9,256,000 after acquiring an additional 3,596 shares during the period. Cox Capital Mgt LLC increased its position in UnitedHealth Group by 4.4% in the second quarter. Cox Capital Mgt LLC now owns 8,491 shares of the healthcare conglomerate’s stock worth $2,072,000 after buying an additional 360 shares during the last quarter. Pensionfund DSM Netherlands increased its position in UnitedHealth Group by 8.0% in the second quarter. Pensionfund DSM Netherlands now owns 24,300 shares of the healthcare conglomerate’s stock worth $5,929,000 after buying an additional 1,800 shares during the last quarter. Pensionfund Sabic increased its position in UnitedHealth Group by 6.6% in the second quarter. Pensionfund Sabic now owns 16,200 shares of the healthcare conglomerate’s stock worth $3,953,000 after buying an additional 1,000 shares during the last quarter. Finally, Fulton Bank N.A. increased its position in UnitedHealth Group by 22.8% in the second quarter. Fulton Bank N.A. now owns 7,436 shares of the healthcare conglomerate’s stock worth $1,815,000 after buying an additional 1,382 shares during the last quarter. Institutional investors own 85.66% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,000 shares of UnitedHealth Group stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the sale, the director now owns 187,979 shares of the company’s stock, valued at $43,517,138.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $232.76, for a total value of $581,900.00. Following the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $43,753,992.04. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,177 shares of company stock valued at $7,842,582. Corporate insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same period in the previous year, the business earned $3.41 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Inc will post 14.96 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
A number of analysts have issued reports on the company. BMO Capital Markets downgraded UnitedHealth Group from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $292.00 to $249.00 in a research report on Monday, September 30th. Mizuho assumed coverage on UnitedHealth Group in a research report on Thursday, October 17th. They issued a “buy” rating and a $270.00 target price for the company. Cantor Fitzgerald set a $310.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Royal Bank of Canada set a $311.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Finally, Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Thursday, August 29th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $283.84.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What do investors mean by earnings per share?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.